Improving sepsis treatment by embracing diagnostic uncertainty.
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Sepsis—life-threatening organ dysfunction due to infection—hospitalizes an estimated 19 million patients every year, more than 5 million of whom die (1). Treatment focuses on timely antibiotic delivery, resuscitation, and source control. Yet, policies promoting early antibiotics are increasingly polarizing. The 2016 Surviving Sepsis Campaign guidelines strongly recommend delivering antibiotics within 1 hour to all patients with sepsis (2). “Rory’s Regulations” mandate that New York State hospitals report compliance with early sepsis treatments for patients diagnosed with sepsis (3). Similarly, the Centers for Medicare & Medicaid Services’ SEP-1 performance measure requires hospitals to report compliance with an early sepsis treatment bundle for patients discharged with a diagnosis of sepsis. These initiatives havemet with disparate responses— simultaneously lauded by some for reducing preventable sepsis deaths and lambasted by others as driving antibiotic overuse (4–6). In 2018, the debate intensified. Highprofile editorials have disputed the logic behind early antibiotics and raised concern about rising antimicrobial resistance and antibiotic-associated harms (7, 8). In May 2018, the Surviving Sepsis Campaign released a new 1-hour treatment bundle strengthening the recommendation that antibiotics be delivered within 60 minutes (9). Shortly thereafter, a grassroots online petition argued that the 1-hour recommendation is likely to cause “indiscriminate use of broadspectrum antibiotics” (10). In July 2018, HospitalCompare.gov released the first public report of SEP-1 performance and revealed that less than 50% of patients with recognized sepsis received all recommended treatments within 3 hours (11). We have observed this debate with interest as intensive care physicians and researchers and, most recently, as members of the Surviving Sepsis Campaign guideline panel and advisors to a nationwide sepsis initiative in the Veterans Affairs Healthcare System. Increasingly, we sense a disconnect between the public conversation and our notion of superb bedside care for patients with sepsis. In contrast to some time-sensitive medical emergencies (e.g., stroke, myocardial infarction), blood work and imaging cannot reliably rule in or rule out sepsis. Sepsis diagnosis depends on clinical judgment. Sometimes it is obvious, but often, especially early in a patient’s presentation, it is unclear whether his or her illness is due to infection. The best clinicians, we believe, simultaneously weigh the likelihood that a patient is infected, consider competing diagnoses, and assess severity of illness. Underlying such reckonings is the knowledge that the consequences of inappropriately withholding antibiotics mount for sicker patients. These subconscious calculations incorporate additional information as it becomes available, with the assessment revised over time. However, the decision to administer antibiotics must often be made when the diagnosis is still uncertain, particularly for the sickest patients. In marked contrast to this clinical reality, sepsis performance is uniformly assessed and reported for a population knowable only in retrospect—the patients ultimately judged to have sepsis at hospital discharge. This causes substantial problems for effective audit and feedback or incentivizing clinician behavior. To improve sepsis care, we should incorporate the following lessons learned:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The imperative to provide antimicrobials as early as possible, however, must be balanced against the potential harms associated with administering unnecessary antimicrobials to patients without infection [99, 100].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [100]
In the citing paper
“The optimal duration of antimicrobial therapy for a given patient with sepsis or septic shock depends on many factors, including host, microbe, drug, and anatomical site (Table 2) [99, 100].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · Chest · doi:10.1378/chest.10-0134 · Cited by 4,505
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
Fleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548
Time to treatment and mortality during mandated emergency care for sepsis.
Seymour, C. W., Gesten, F., Prescott, H. C., Friedrich, M. E., Iwashyna, T. J., Phillips, G. S., Lemeshow, S., Osborn, T., Terry, K. M., & Levy, M. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703058 · Cited by 2,225
Self-citationThe surviving sepsis campaign bundle: 2018 update
Levy, M. M., Evans, L. E., & Rhodes, A. (2018) · Intensive Care Medicine · doi:10.1007/s00134-018-5085-0 · Cited by 1,445
The Surviving Sepsis Campaign Bundle: 2018 Update
Levy, M. M., Evans, L. E., & Rhodes, A. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003119 · Cited by 679
Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection
Huang, D. T., Yealy, D. M., Filbin, M. R., Brown, A. M., Chang, C.-C. H., Doi, Y., Donnino, M. W., Fine, J., Fine, M. J., Fischer, M. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1802670 · Cited by 434
Regulatory Mandates for Sepsis Care — Reasons for Caution
Rhee, C., Gohil, S., & Klompas, M. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1400276 · Cited by 231
Antibiotics for sepsis-finding the equilibrium.
Klompas, M., Calandra, T., & Singer, M. (2018) · JAMA · doi:10.1001/jama.2018.12179 · Cited by 183
Research works printed but not linked: 2
- Dwyer, 2017 13, A boy’s life is lost to sepsis. Thousands are saved in his wake, A18
- Aberegg, 2018 2, Petition to retire the Surviving Sepsis Campaign guidelines
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citationVaughn, V. M., Gandhi, T. N., Petty, L. A., Patel, P. K., Prescott, H. C., Malani, A. N., Ratz, D., McLaughlin, E., Chopra, V., & Flanders, S. A. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1239 · Cited by 396
“Finally, we need better training and understanding of how to incorporate imperfect tests and diagnostic uncertainty into decision making [27].”
BackgroundSelf-citationEarly Prediction of Sepsis From Clinical Data: The PhysioNet/Computing in Cardiology Challenge 2019
Reyna, M. A., Josef, C. S., Jeter, R., Shashikumar, S. P., Westover, M. B., Nemati, S., Clifford, G. D., & Sharma, A. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004145 · Cited by 383
2023 Update on Sepsis and Septic Shock in Adult Patients: Management in the Emergency Department
Guarino, M., Perna, B., Cesaro, A. E., Maritati, M., Spampinato, M. D., Contini, C., & De Giorgio, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093188 · Cited by 294
“However, the urgent need to establish antimicrobial treatment should be carefully pondered in terms of potential harm related to drugs administered to patients without an infection [2,26,27].”
BackgroundAntibiotic failure: Beyond antimicrobial resistance
de la Fuente-Nunez, C., Cesaro, A., & Hancock, R. E. W. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101012 · Cited by 254
Baghela, A., Pena, O. M., Lee, A. H., Baquir, B., Falsafi, R., An, A., Farmer, S. W., Hurlburt, A., Mondragon-Cardona, A., Rivera, J. D., et al. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2021.103776 · Cited by 209
Rhee, C., Chiotos, K., Cosgrove, S. E., Heil, E. L., Kadri, S. S., Kalil, A. C., Gilbert, D. N., Masur, H., Septimus, E. J., Sweeney, D. A., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa059 · Cited by 191
“Recommended Revisions to the National SEP-1 Sepsis Quality Measure • cid 2021:72 (15 February) • 545 ambiguous, in many cases clinicians can safely take additional time to obtain laboratory and imaging results and assess the impact of nonantibiotic therapies; even a few short hours can be highly informative in helping…”
BackgroundAntimicrobial-associated harm in critical care: a narrative review
Arulkumaran, N., Routledge, M., Schlebusch, S., Lipman, J., & Conway Morris, A. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05929-3 · Cited by 175
Strich, J. R., Heil, E. L., & Masur, H. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa221 · Cited by 188
“Given the significant burden of sepsis, starting antibiotic therapy is a decision that clinicians face at the bedside on a daily basis, influenced by many different patient factors including presenting signs and symptoms, comorbidities, severity of illness, likelihood of infection, risk associated with delayed antibio…”
BackgroundEarly Prediction of Sepsis from Clinical Data: The PhysioNet/Computing in Cardiology Challenge 2019
Reyna, M., Prajwal Shashikumar, S., Moody, B., Gu, P., Sharma, A., nemati, S., & Clifford, G. (2019) · Computing in Cardiology Conference (CinC) · doi:10.22489/cinc.2019.412 · Cited by 153
Petty, L. A., Vaughn, V. M., Flanders, S. A., Malani, A. N., Conlon, A., Kaye, K. S., Thyagarajan, R. V., Osterholzer, D., Nielsen, D. L., Eschenauer, G. A., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.2871 · Cited by 169
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Intensive Care Medicine · doi:10.1007/s00134-026-08361-1 · Cited by 141
Self-citationSurviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock 2026
Prescott, H. C., Antonelli, M., Alhazzani, W., Møller, M. H., Alshamsi, F., Azevedo, L. C. P., Belley-Cote, E., De Waele, J., Derde, L., Dionne, J. C., et al. (2026) · Critical Care Medicine · doi:10.1097/ccm.0000000000007075 · Cited by 117
Self-citationTarabichi, Y., Cheng, A., Bar-Shain, D., McCrate, B. M., Reese, L. H., Emerman, C., Siff, J., Wang, C., Kaelber, D. C., Watts, B., et al. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005267 · Cited by 76
“Such realworld delays are likely attributable to the fact that many patients who are ultimately diagnosed with sepsis do not manifest overt signs of the condition on arrival as well as the likelihood that patients presenting with milder phenotypes warranted a more measured approach (5, 35).”
BackgroundTaylor, S. P., Anderson, W. E., Beam, K., Taylor, B., Ellerman, J., & Kowalkowski, M. A. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004863 · Cited by 78
“Because nearly 40% of patients initially treated for sepsis may ultimately have an alternative condition (16, 17), our results suggest that allowing longer time for additional diagnostic investigations prior to antibiotic use may be reasonable for patients with suspected sepsis (7).”
BackgroundResultEmpirical antibiotic therapy for sepsis: save the anaerobic microbiota
Kullberg, R. F. J., Haak, B. W., Chanderraj, R., Prescott, H. C., Dickson, R. P., & Wiersinga, W. J. (2024) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(24)00257-1 · Cited by 67
Self-citationLanckohr, C., & Bracht, H. (2022) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000967 · Cited by 75
Diagnosis of bacterial sepsis: why are tests for bacteremia not sufficient?
Sweeney, T. E., Liesenfeld, O., & May, L. S. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1660644 · Cited by 76
Pak, T. R., Young, J. G., McKenna, C. S., Agan, A. A., DelloStritto, L. K., Filbin, M. R., Dutta, S., Kadri, S. S., Septimus, E. J., Rhee, C., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad450 · Cited by 64
Ducharme, J., Self, W. H., Osborn, T. M., Ledeboer, N. A., Romanowsky, J., Sweeney, T. E., Liesenfeld, O., & Rothman, R. E. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10040266 · Cited by 54
“From a clinical perspective, sepsis can be visualized along two “axes”, namely, the presence of an infection and the severity of the condition (Figure 1a) [12,13].”
Early Prediction of Sepsis from Clinical Data: the PhysioNet/Computing in Cardiology Challenge 2019
Reyna, M. A., Josef, C. S., Seyedi, S. S., Jeter, R., Shashikumar, S. P., Westover, M. B., Sharma, A., Nemati, S., & Clifford, G. D. (2019) · Computing in cardiology · doi:10.23919/cinc49843.2019.9005736 · Cited by 47
Liesenfeld, O., Arora, S., Aufderheide, T. P., Clements, C. M., DeVos, E., Fischer, M., Giamarellos‐Bourboulis, E. J., House, S. L., Humphries, R. L., Gill, J. K., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03933-y · Cited by 49
“Patients with suspected acute infection or suspected sepsis need to be evaluated along two clinical ‘axes’ (infection and severity) for appropriate treatment 6 .”
InfluentialZhang, J., Yan, W., Dong, Y., Luo, X., Miao, H., Maimaijuma, T., Xu, X., Jiang, H., Huang, Z., Qi, L., et al. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-24-1191 · Cited by 53
“However, the necessity of the early use of antibiotics must be balanced with the potential harm associated with providing unnecessary antibiotics to uninfected patients (129,130).”
Screening strategies to identify sepsis in the prehospital setting: a validation study
Lane, D. J., Wunsch, H., Saskin, R., Cheskes, S., Lin, S., Morrison, L. J., & Scales, D. C. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.190966 · Cited by 49
Antibiotic therapy for severe bacterial infections
Timsit, J., Ling, L., de Montmollin, É., Bracht, H., Morris, A. C., Bus, L. D., Falcone, M., Harris, P. N. A., Machado, F. R., Paiva, J.-A., et al. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-08063-0 · Cited by 46
“Broader spectrum [38, 96, 97], longer duration [98–100], combination therapy [101], and repeated courses increase the likelihood of side effects and superinfections.”
Hooper, G. A., Klippel, C., McLean, S. R., Stenehjem, E. A., Webb, B. J., Murnin, E., Hough, C. L., Bledsoe, J. R., Brown, S. M., & Peltan, I. D. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad101 · Cited by 41
“This finding suggests that clinical decision support or other methods aiding evaluation of patients with an “unknown” infection source diagnosis as well as recent recommendations advocating less urgency for antibiotic initiation when there is uncertainty around the sepsis diagnosis and shock is absent could help reduc…”
BackgroundResultWayne, M. T., Seelye, S. M., Molling, D. J., Wang, X. Q., Donnelly, J. P., Hogan, C. K., Jones, M., Iwashyna, T. J., Liu, V. X., & Prescott, H. C. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.23950 · Cited by 39
Self-citationКirov, М. Y., Владимирович, К. В., Николаевич, П. Д., Щеголев, А. В., Babaev, M. A., Belotserkovskiy, B. Z., Bykov, A. O., Gritsan, A. I., Кулабухов, В. В., Kulikov, A. V., et al. (2023) · Annals of critical care · doi:10.21320/1818-474x-2023-4-7-42 · Cited by 44
What is new and different in the 2021 Surviving Sepsis Campaign guidelines
Prescott, H. C., & Ostermann, M. (2023) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-023-01028-5 · Cited by 45
Self-citationTime to treatment and mortality for clinical sepsis subtypes
Yang, A., Kennedy, J. N., Reitz, K. M., Phillips, G. S., Terry, K. M., Levy, M. M., Angus, D. C., & Seymour, C. W. (2023) · Critical Care · doi:10.1186/s13054-023-04507-5 · Cited by 42
“First, the conceptual rationale has face validity, which advances that one sepsis patient does not always need to or respond to the same treatment as the second [21].”
BackgroundS3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge – Update 2025
Brunkhorst, F. M., Adamzik, M., Axer, H., Bauer, M. W., Bode, C., Bone, H.-G., Brenner, T., Bucher, M., David, S., Dietrich, M., et al. (2025) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-025-01317-1 · Cited by 47
Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality
Martín-Fernández, M., Heredia‐Rodríguez, M., González-Jiménez, I., Lorenzo‐López, M., Gómez‐Pesquera, E., Poves‐Álvarez, R., Alvarez, E., Jorge-Monjas, P., Beltrandeheredia, J., Gutiérrez‐Abejón, E., et al. (2022) · Critical Care · doi:10.1186/s13054-021-03875-0 · Cited by 32
“The optimal duration of antimicrobial therapy for a given sepsis/ septic shock patient depends on several factors [57, 58].”
BackgroundShappell, C. N., Yu, T., Klompas, M., Agan, A. A., DelloStritto, L. K., Faine, B. A., Filbin, M. R., Mohr, N. M., Park, S. T., Plechot, K., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf118 · Cited by 31
Christensen, E. E., Binde, C., Leegaard, M., Tonby, K., Dyrhol‐Riise, A. M., Kvale, D., Amundsen, E., & Holten, A. R. (2022) · Shock · doi:10.1097/shk.0000000000001981 · Cited by 30
“Lastly, the choice to treat severely ill patients with antibiotics might reflect caution rather than conviction of infection as underlying cause, as discussed by Prescott and Iwashyna (36).”
BackgroundPrescott, H. C., Seelye, S. M., Wang, X. Q., Hogan, C. K., Smith, J. T., Kipnis, P., Barreda, F. X., Donnelly, J. P., Pogue, J. M., Iwashyna, T. J., et al. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.2291 · Cited by 27
Self-citationChallenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies
Rueda, F. R., Nieves‐Alonso, J., Villabona, E. G., Vallejo, C., Kattan, E., & Méndez, R. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14020176 · Cited by 29
“…shock based on the experience of this study’s authors and the best available evidence to defend their arguments, understanding that the complexity of sepsis should not confine clinicians to a single mental model of care, but rather open them to possibilities in a context of uncertainty [15,16].”
BackgroundDeveloping a shared sepsis data infrastructure: a systematic review and concept map to FHIR
Brant, E. B., Kennedy, J. N., King, A. J., Gerstley, L. D., Mishra, P., Schlessinger, D., Shalaby, J., Escobar, G. J., Angus, D. C., Seymour, C. W., et al. (2022) · npj Digital Medicine · doi:10.1038/s41746-022-00580-2 · Cited by 29
Towards an Explainable Model for Sepsis Detection Based on Sensitivity Analysis
Chen, M., & Hernández, A. (2022) · IRBM · doi:10.1016/j.irbm.2021.05.006 · Cited by 23
“Nevertheless, the fundamental need for early and reliable identification of sepsis remains unmet [22].”
BackgroundHospital-Onset Sepsis Warrants Expanded Investigation and Consideration as a Unique Clinical Entity
Ginestra, J. C., Yataco, A. C., Dugar, S. P., & Dettmer, M. R. (2024) · CHEST Journal · doi:10.1016/j.chest.2024.01.028 · Cited by 23
“47 Identi fi cation of clinical phenotypes may be helpful to examine the risks and bene fi ts of resuscitation and treatment strategies among subgroups of patients with HOS, informing targeted enrollment in clinical trials enriched for patients most likely to bene fi t from given treatment arms.”
BackgroundTime to administration of antibiotics and mortality in sepsis
Siewers, K., Abdullah, S. M. O. B., Sørensen, R. H., & Nielsen, F. E. (2021) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.12435 · Cited by 21
Klompas, M., Ochoa, A., Ji, W., McKenna, C. S., Clark, R., Shenoy, E. S., Hooper, D. C., & Rhee, C. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.10700 · Cited by 18
Current Controversies in Sepsis Management
Moss, S. R., & Prescott, H. C. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1696981 · Cited by 15
Self-citationTrial of antibiotic restraint in presumed pneumonia: A Surgical Infection Society multicenter pilot
Guidry, C. A., Beyene, R. T., Watson, C. M., Sawyer, R. G., Chollet‐Hinton, L., Simpson, S. Q., Atchison, L., Derickson, M. J., Cooper, L., Pennington, G. P., et al. (2022) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000003839 · Cited by 14
“Diagnostic uncertainty is an inherent, but frequently ignored, aspect of the treatment of pneumonia and sepsis.(13) Our limited findings suggest, as the current SSC guidelines advise, that a short period of additional diagnostic workupmay be safe in selected low-risk patients who do not require vasopressors.”
ResultImpact of Reducing Time-to-Antibiotics on Sepsis Mortality, Antibiotic Use, and Adverse Events
Donnelly, J. P., Seelye, S. M., Kipnis, P., McGrath, R., Iwashyna, T. J., Pogue, J. M., Jones, M., Liu, V. X., & Prescott, H. C. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202306-505oc · Cited by 25
Self-citationSilvestri, J. A., Kmiec, T. E., Bishop, N. S., Regli, S. H., & Weissman, G. E. (2022) · JMIR Human Factors · doi:10.2196/36976 · Cited by 12
“Clinical decision-making regarding sepsis treatment is imbued with uncertainty related to both the diagnosis and the severity of the presentation [14].”
BackgroundAntimicrobial treatment imprecision: an outcome-based model to close the data-to-action loop
Howard, A., Reza, N., Aston, S., Woods, B. S., Gerada, A., Buchan, I. E., Hope, W. W., & Märtson, A. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00367-5 · Cited by 12
Usher, M. G., Tourani, R., Webber, B., Tignanelli, C. J., Ma, S., Pruinelli, L., Rhodes, M., Sahni, N., Olson, A. P. J., Melton, G. B., et al. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005429 · Cited by 11
“Interventions aimed at improving the care of these critically ill patients may have less incremental benefit than those aimed, paradoxically, at lower risk patients for whom diagnoses and appropriate treatment may be less clear but who may also be at risk for poor outcomes (33, 34).”
BackgroundFigueiredo-Pereira, C., Fleming, P., Alganes, M. N., Bi, R., Cavaleiro, A. M., CRUZ, D. Z. D. N., Cunha-Matos, C., Davalos-Arias, M., Farkas, D., Hasin-Brumshtein, Y., et al. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.00352-25 · Cited by 11
A Quantitative Study of Decision Thresholds for Initiation of Antibiotics in Suspected Sepsis
Taylor, S. P., Weissman, G. E., Kowalkowski, M. A., Admon, A. J., SKEWES, S. A., Xia, Y., & Chou, S.-H. (2022) · Medical Decision Making · doi:10.1177/0272989x221121279 · Cited by 10
New biomarkers for respiratory infections
Póvoa, P. M. S. R., Coelho, L., & Bos, L. D. J. (2020) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000669 · Cited by 11
“The likelihood of giving antibiotics is a function of pretest probability and the negative effects of not giving antibiotics [11].”
BackgroundAntibiotic Order-to-Infusion Time for Patients With Septic Shock: A Potential New Quality Metric*
Klompas, M., & Rhee, C. (2019) · Critical Care Medicine · doi:10.1097/ccm.0000000000003940 · Cited by 9
Martin, M., Forveille, S., Lascarrou, J.-B., Seguin, A., Canet, E., Lemarie, J., Agbakou, M., Desmedt, L., Blonz, G., Zambon, O., et al. (2024) · Annals of Intensive Care · doi:10.1186/s13613-024-01243-z · Cited by 9
“Tailoring the AT strategy to disease severity is in line with the current interest in personalized sepsis management [39, 41–43].”
ResultReal time self-rating of decision certainty by clinicians: a systematic review
Nagendran, M., Chen, Y., & Gordon, A. C. (2019) · Clinical Medicine · doi:10.7861/clinmed.2019-0169 · Cited by 8
Syndromic Analysis of Sepsis Cohorts Using Large Language Models
Pak, T. R., Kanjilal, S., McKenna, C. S., Hoffner-Heinike, A., Rhee, C., & Klompas, M. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.39267 · Cited by 9
Machine Learning Models for Early Prediction of Malignancy in Sepsis Using Clinical Dataset
Divya, B., & Mehta, D. (2023) · International Conference on Smart Systems for Applications in Electrical Sciences (ICSSES) · doi:10.1109/icsses58299.2023.10201213 · Cited by 7
“However, reliable and early sepsis identification is a crucial need that is not yet met [8].”
BackgroundSurviving Sepsis Screening: The Unintended Consequences of Continuous Surveillance
Harrison, W. N., Workman, J. K., Bonafide, C. P., & Lockwood, J. M. (2020) · Hospital Pediatrics · doi:10.1542/hpeds.2020-002121 · Cited by 7
“Another benefit of model-based approaches is the ability to report the likelihood of sepsis as a continuous probability, enabling graded rather than dichotomized responses.(33) For example, low-risk patients could receive increased monitoring and supportive therapies (eg, antipyretics), with complete bundles reserved…”
BackgroundBaghdadi, J. D., Goodman, K. E., Magder, L. S., Heil, E. L., Claeys, K. C., Bork, J. T., & Harris, A. D. (2023) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlad054 · Cited by 7
Townsend, S. R., Rivers, E. P., & Duseja, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa458 · Cited by 6
Kwak, H., Kwon, W. Y., Jo, Y. H., Kim, S., Suh, G. J., Kim, K. S., Jung, Y. S., Lee, H. J., & Kim, J. Y. (2024) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2024.06.031 · Cited by 7
We Dissent: Lessons From the 2025 Community-Acquired Pneumonia Guidelines
Hojat, L. S., Laguio-Vila, M. R., Sullivan, L. R., & Vaughn, V. M. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf626 · Cited by 5
Smart Imitator: Learning from Imperfect Clinical Decisions
Perera, D., Liu, S., See, K. C., & Feng, M. (2024) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocae320 · Cited by 9
Prasad, P. A., Esmaili, A. M., Oreper, S., Beagle, A. J., Hubbard, C. C., Raffel, K. E., Abe‐Jones, Y., Fang, M. C., Liu, K. D., Matthay, M. A., et al. (2024) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.13149 · Cited by 5
“22 It also highlights the necessary minority of patients requiring sepsis “overtreatment,” particularly among those at high risk of mortality.”
BackgroundManaging Clinical Uncertainty: Formalizing Management Reasoning in Emergency Care Delivery
Haimovich, A. D., Janke, A. T., Kocher, K. E., Mangus, C. W., Parsons, A. S., McCoy, L. G., Taylor, R. A., Rodman, A. M., & Pusic, M. V. (2025) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2025.09.007 · Cited by 6
Early Clinical Management of Sepsis: Past, Present, and Future
Anyalebechi, J. C., & Coopersmith, C. M. (2022) · Journal of Translational Critical Care Medicine · doi:10.4103/jtccm-d-22-00016 · Cited by 4
Effect of dilution on sedimentational separation of bacteria from blood
Anderson, C. M., & Pitt, W. G. (2020) · Biotechnology Progress · doi:10.1002/btpr.3056 · Cited by 4
“Therefore most physicians initially treat septic shock with broad-spectrum antibiotics while waiting for species identification and antibiotic resistance profiles that enable more specific antibiotic therapy.(2,4) The emerging need of better antimicrobial stewardship, including less use of broad-spectrum antibiotics,…”
BackgroundChallenging the Dogma of Aggressive Initiation of Antibiotics in Sepsis
Guidry, C. A., Sawyer, R. G., & Winfield, R. D. (2020) · Surgical Infections · doi:10.1089/sur.2020.244 · Cited by 4
“If we accept diagnostic uncertainty as part of our sepsis treatment pathway, it becomes clear that our current ‘‘one-size-fits-all’’ approach to antibiotic initiation is unnecessary and may be harmful [10,12].”
Early Prediction of Sepsis using Ensemble Learning
Nahar, A., Hemanth, K. S., & Abirami, G. (2023) · International Conference on Artificial Intelligence for Innovations in Healthcare Industries (ICAIIHI) · doi:10.1109/icaiihi57871.2023.10489253 · Cited by 3
“As such, the identification of sepsis at an early stage is critical and a continuous challenge [13].”
BackgroundMunroe, E. S., & Prescott, H. C. (2025) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2025.10.001 · Cited by 5
Self-citationHaas, L. E. M., de Lange, D. W., & Martín‐Loeches, I. (2022) · Lessons from the ICU · doi:10.1007/978-3-030-94133-8_30 · Cited by 4
Antibiotics: it is all about timing, isn’t it?
Klompas, M., & Rhee, C. (2022) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000969 · Cited by 4
Hill, T. M., Kerivan, L. T., Vilain, K. R., Windham, S., Sarani, N., Simpson, S. Q., & Guidry, C. A. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-07899-w · Cited by 3
“Some authors have advocated for policies that embrace the ‘diagnostic uncertainty’ inherent in sepsis treatment allowing for additional time to identify non-infectious causes of organ dysfunction [18, 19].”
Taylor, S. P., Palakshappa, J. A., Chou, S., Gibbs, K. W., King, J., Patel, N., & Kowalkowski, M. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae445 · Cited by 2
Prescott, H. C., Heath, M. E., Walzl, E., McLaughlin, E. S., Horowitz, J., Jayaprakash, N., Flanders, S. A., Dantes, R., & Posa, P. J. (2026) · American Journal of Respiratory and Critical Care Medicine · doi:10.1093/ajrccm/aamaf113 · Cited by 2
Self-citationAntibiotic timing and progression to sepsis among patients in the ED for infection
Lin, X., Liu, C., Chen, F., Xie, H., Xie, A., Wang, L., Chen, C., Wang, Z., Weng, J., & Chen, Y. (2026) · European journal of medical research · doi:10.1186/s40001-026-03971-3 · Cited by 2
“This suggests that in patients with suspected sepsis, it may be reasonable to allow more time for additional diagnostic tests before administering antibiotics [25].”
Winter, A., Jones, W. S., Allen, A. J., Price, D., Rostron, A., Filieri, R., & Graziadio, S. (2020) · Antibiotics · doi:10.3390/antibiotics9110737 · Cited by 2
“There is much debate amongst the sepsis community over the introduction of time targets to administer antibiotics, with some stating that they have reduced preventable deaths and others arguing that they drive the overuse of broad-spectrum antibiotics [14].”
BackgroundTamma, P. D., Miller, M. A., & Cosgrove, S. E. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202005-484ip · Cited by 3
Impact of hourly serial SOFA score on signaling emerging sepsis
Ho, B.-S., Lee, Y. W., & Lin, Y. (2022) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2022.100999 · Cited by 2
“During times of diagnostic uncertainty, the timing and broadness of initial antibiotics vary with the likelihood of bacterial infection and the illness severity, and the optimal treatment may differ across patients [9].”
BackgroundKosyreva, A. M., Dzhalilova, D. S., Miroshnichenko, E. A., & Makarova, O. V. (2024) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-025-06318-w · Cited by 2
“High mortality from sepsis is associated with individual differences in the severity of the disease and the absence of reliable prognostic markers, which makes it difficult to time - ly diagnose the condition and select the appropriate treatment strategy [2,3].”
Finding the balance between overtreatment versus undertreatment for hospital-acquired pneumonia
Klompas, M., & Baker, D. L. (2021) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.474 · Cited by 2
Sepsis in the intensive care unit: from definitions to outcomes
Driessen, R. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220407rd · Cited by 2
Antimicrobials in Sepsis: Time to Pay Attention to When Delays Happen
Lyons, P. G., & Hough, C. L. (2023) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202306-519ed · Cited by 1
Antibiotics, Antivirals, and Antifungals in Critical Care
Shamshirsaz, A. A., & Vaught, A. “. J. (2024) · Wiley eBooks · doi:10.1002/9781119820260.ch19 · Cited by 1
Kamran, F., Tjandra, D., Valley, T. S., Prescott, H. C., Shah, N. H., Liu, V. X., Horvitz, E., & Wiens, J. (2025) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaf036 · Cited by 1
Self-citationSzymański, M., Skiba, M. M., & Piasecka, M. (2025) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.70021 · Cited by 1
Sepsis Diagnostic Excellence and Its Association With Mortality in Adults With Potential Infection
Kowalkowski, M. A., Birken, S. A., Obermiller, C. S., Miller, C. D., Palakshappa, J. A., Rowland, B., King, J., Rogers, T., Tian, S., Shrestha, S., et al. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag382 · Cited by 1
Antibiotic Initiation Timing and Mortality in Trauma Patients With Ventilator-Associated Pneumonia
O’Dell, J. C., Halimeh, B. N., Johnston, J. B., McCoy, C. C., Winfield, R. D., & Guidry, C. A. (2022) · The American Surgeon · doi:10.1177/00031348221129518 · Cited by 1
“2,3,10,11,19 We found no signi fi cant difference in median time to antibiotic administration between survivors and non-survivors.”
BackgroundLi, Y., Wang, Y., Guo, J., Li, H., Yang, H., & Zhang, D. (2022) · Research Square · doi:10.21203/rs.3.rs-2318958/v1 · Cited by 1
Cook, C., & Simpson, S. Q. (2019) · The Southwest Respiratory and Critical Care Chronicles · doi:10.12746/swrccc.v7i31.605
Adamu, S. A., Ballah, A. M., Panda Shehu, U., Ma, H., Buma, G., Dakum, L., Mufutau Jimoh, L., & Alfa, N. (2021) · International Journal of Anesthetics and Anesthesiology · doi:10.23937/2377-4630/1410128
Guidry, C. A., & Sawyer, R. G. (2022) · Springer eBooks · doi:10.1007/978-3-031-07881-1_34
Herd, S., Allen, P., Reed, L. J., O'Hern, J. A., Fraser, J. L., & Flanagan, K. L. (2023) · Emergency Medicine Australasia · doi:10.1111/1742-6723.14206 · Cited by 2
Zhang, C., Huang, H., & Bai, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-3184567/v1
Die aktuelle Sepsisleitlinie – was müssen Sie wissen?
Kochanek, M., & David, S. (2023) · Die Innere Medizin · doi:10.1007/s00108-023-01585-z
Unpacking Regionalization of Sepsis Care Using Hospital Capability Assessments*
Anesi, G. L., & Admon, A. J. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000005987
Provider Perceptions of Antibiotic Initiation Strategies for Hospital-Acquired Pneumonia
Swilling, A. C., O’Dell, J. C., Beyene, R. T., Watson, C. M., Sawyer, R. G., Chollet‐Hinton, L., Simpson, S. Q., Atchison, L., Derickson, M. J., Cooper, L., et al. (2024) · Surgical Infections · doi:10.1089/sur.2023.310
Kochanek, M., & David, S. (2024) · Wiener klinisches Magazin · doi:10.1007/s00740-024-00527-1
Pappas, M. A., Herzig, S. J., Auerbach, A. D., Deshpande, A., Blanchard, E. J., & Rothberg, M. B. (2025) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2025.10
Making the Diagnosis and Managing Diagnostic Uncertainty in Acute Neurologic Presentations
Janke, A. T., & Haimovich, A. D. (2025) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2025.07.024
Metadata
- Authors
- Prescott, H. C., & Iwashyna, T. J.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Prescott, Hallie C.
- Venue
- Annals of the American Thoracic Society
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-04-01
- Volume
- 16
- Issue
- 4
- Pages
- 426-429
- ISSN
- 2325-6621 (ISSN-L)
- 2329-6933
- PMC
- PMC6441693
- OpenAlex
- W2921622535
- Cited by
- 110
- References
- 17
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 15 · 2023: 17 · 2022: 19 · 2021: 9 · 2020: 14 · 2019: 9
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of the American Thoracic Society (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 HX002546)
- Health Services Research and Development
- National Institutes of Health
- National Heart, Lung, and Blood Institute (K12HL138039)
- National Institute of General Medical Sciences (K08GM115859)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Family Practice › Clinical Reasoning and Diagnostic Skills
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- sepsis, diagnostic uncertainty, sepsis treatment, clinical decision-making, sepsis diagnosis
- MeSH terms
- Clinical Decision-Making, Clinical Competence, Delivery of Health Care, Humans, Sepsis, Disease Management, Uncertainty
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.